Inspire Trust Company’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.67M Hold
20,000
0.57% 73
2025
Q4
$3.52M Hold
20,000
0.58% 75
2025
Q3
$2.8M Buy
20,000
+2,000
+11% +$270K 0.51% 80
2025
Q2
$2.26M Buy
18,000
+3,700
+26% +$461K 0.47% 85
2025
Q1
$1.96M Buy
14,300
+2,000
+16% +$286K 0.47% 85
2024
Q4
$1.88M Buy
12,300
+1,400
+13% +$236K 0.48% 83
2024
Q3
$2.11M Buy
10,900
+4,025
+59% +$842K 0.58% 70
2024
Q2
$1.59M Buy
6,875
+2,100
+44% +$456K 0.53% 72
2024
Q1
$1.03M Buy
4,775
+2,500
+110% +$586K 0.57% 68
2023
Q4
$589K Buy
+2,275
New +$559K 0.61% 58

Other funds holding BIIB

Inspire Trust Company's BIIB Position: Q1 2026 in Review

Inspire Trust Company held its Biogen (BIIB) position steady in Q1 2026 at 20,000 shares worth $3.67M. The position accounts for 0.57% of the portfolio, ranked #73.

Inspire Trust Company first reported a position in BIIB in Q4 2023 and has held it in 10 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Inspire Trust Company held 20,000 shares of Biogen worth $3.67M as of Q1 2026.
  • Inspire Trust Company left its Biogen share count unchanged in Q1 2026.
  • Biogen made up 0.57% of Inspire Trust Company's portfolio in Q1 2026, its #73 holding.
  • Inspire Trust Company first reported a position in Biogen in Q4 2023 and has held it in 10 quarters since.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Inspire Trust Company's 13F filing for Q1 2026, filed 12 May 2026.